| Previous Close | 217.00 |
| Open | 211.90 |
| Bid | 0.00 x 1100 |
| Ask | 0.00 x 1800 |
| Day's Range | 211.80 - 218.90 |
| 52 Week Range | 54.21 - 227.71 |
| Volume | 5,576,026 |
| Avg. Volume | 9,537,106 |
| Market Cap | 87.874B |
| Beta (5Y Monthly) | 1.47 |
| PE Ratio (TTM) | 146.68 |
| EPS (TTM) | 1.49 |
| Earnings Date | Aug. 03, 2021 - Aug. 09, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 181.17 |
- Motley Fool
3 Reasons to Buy Moderna, and 1 Reason to Sell
Moderna already has signed contracts worth $19.2 billion in product sales this year. First, Moderna aims to have a booster ready by fall. Moderna also will benefit if regulatory agencies authorize its vaccine in new groups such as teens and kids.
- Yahoo Finance Video
Seattle becomes first major U.S.city with 70% fully vaccinated
Seattle Mayor Jenny Durkan joined Yahoo Finance to break down how her city has been so sucsseful in distrubting vaccines.Â
- Yahoo Finance Video
CDC plans 'emergency meeting' over COVID-19 vaccine side effects
Yahoo Finance's Anjalee Khemlani reports on the CDC's plans for an 'emergency meeting' over COVID-19 vaccine side effects.
© 2021 Verizon Media. All rights reserved.
